Overview

Laser Peripheral Iridotomy Plus Laser Peripheral Iridoplasty for Primary Angle Closure

Status:
Recruiting
Trial end date:
2022-04-01
Target enrollment:
Participant gender:
Summary
This is a 10-centre randomized controlled clinical trial to explore whether laser peripheral iridoplasty (LPIP) plus laser peripheral iridotomy (LPI) is more effective than single LPI to control the progression of primary angle closure with multi-mechanism based on the UBM classification.
Phase:
N/A
Details
Lead Sponsor:
Sun Yat-sen University
Collaborators:
Beijing Tongren Hospital
Central South University
He University
Hebei Provincial Eye Hospital
Huazhong University of Science and Technology
The Second Affiliated Hospital of Harbin Medical University
The Third Hospital of HanDan
Third Affiliated Hospital of Third Military Medical University
Wenzhou Medical University
Treatments:
Anesthetics
Pilocarpine
Propoxycaine
Proxymetacaine